Antibody Protein ELISA Kit from MyBioSource header Telephone 1.858.633.0165          
Fax 1.858.633.0166    Email 
menu1 Home Products Ordering Company Help menu7
   MyBioSource  rightarrow Blog  rightarrow SPATA31A7 sirna  rightarrow LOG IN  rightarrow MY ACCOUNT  rightarrow CART CONTENTS  rightarrow CHECKOUT 
horiz bar
MyBioSource Blogs moreseparator
 • GR elisa kit blog
 • C5a elisa kit blog
 • anti-RSF1 antibody blog
 • ELOVL2 sirna blog
 • IMPG1 sirna blog
 • LNX1 sirna blog
 • anti-LIPF antibody blog
 • IRAK3 blocking peptide blog
 • HBsAg recombinant protein blog
 • NOD2 elisa kit blog
 • hsa-miR-4720-5p mirna blog
 • WDSUB1 sirna blog
 • ZNF2 sirna blog
 • Metamorphosin A peptide blog
 • ZNF276 sirna blog
 • OPG elisa kit blog
 • Tissue, Array Disease tissue array blog
 • ATMA elisa kit blog
 • ITGA3 shrna blog
 • WDR78 sirna blog
Blog Categories separator
 • Assay Kit Blogs
 • Biochemical Blogs
 • cDNA Clone Blogs
 • Monoclonal Antibody Blogs
 • Polyclonal Antibody Blogs
 • Rec/Purified Protein Blogs
 • Popular Product Blogs
Our Best Sellers moreseparator
 • GLYAT Recombinant Protein
 • Superoxide Dismutase (SOD) ELISA Kit
 • FZD5 Antibody
 • cGMP-specific 3',5'-cyclic phosphodiesterase (PDE5A) ELISA Kit
 • ZNF529 Antibody
 • PRG2 Antibody
 • Cytochrome c (CYCS) Antibody
 • Levo-Alpha-Acethylmetadol (LAAM) HRP Conjugate
 • ABL1-Y204 Antibody
 • Parainfluenza Virus Type-1 Native Protein
 • tripartite motif-containing 32 (TRIM32) Antibody
 • DNA topoisomerase 2-alpha (Top2a) ELISA Kit
 • zinc finger and BTB domain containing 16 (ZBTB16) ELISA Kit
 downarrow more ...

SPATA31A7 sirna product blog

Posted on 2017-08-19 08:52:54 by mybiosource_staff
Share it on ...     
Tags: siRNA; SPATA31A7; SPATA31A7 sirna;
The SPATA31A7 spata31a7 (Catalog #MBS8203592) is a siRNA produced from Synthetic and is intended for research purposes only. The product is available for immediate purchase. The SPATA31A7 siRNA (Human) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s SPATA31A7 can be used in a range of immunoassay formats including, but not limited to, RNA Interference (RNAi). Researchers should empirically determine the suitability of the SPATA31A7 spata31a7 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.

The SPATA31A7 spata31a7 product has the following accession number(s) (GI #153791826) (NCBI Accession #NP_056482.2) (Uniprot Accession #Q8IWB4). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.

To buy or view more detailed product information and pricing, please click on the technical datasheet page below:

siRNA to inhibit SPATA31A7 expression using RNA interference.

SPATA31A7 spata31a7

Quality Control: Oligonucleotide synthesis is monitored base by base through trityl analysis to ensure appropriate coupling efficiency. The oligo is subsequently purified by affinity-solid phase extraction. The annealed RNA duplex is further analyzed by mass spectrometry to verify the exact composition of the duplex. Each lot is compared to the previous lot by mass spectrometry to ensure maximum lot-to-lot consistency.
Directions for Use: We recommends transfection with 100 nM siRNA 48 to 72 hours prior to cell lysis. Before resuspending, briefly centrifuge the tube to ensure the lyophilized siRNA is at the bottom of the tube. Resuspend the siRNA oligos to an appropriate concentration with DEPC water. For each vial, suitable for 250 transfections in 24 well plate (20 pmol for each well).
Components: We offer pre-designed sets of 3 different target-specific siRNA oligo duplexes of human SPATA31A7 gene. Each vial contains 5 nmol of lyophilized siRNA. The duplexes can be transfected individually or pooled together to achieve knockdown of the target gene, which is most commonly assessed by qPCR or western blot. Our siRNA oligos are also chemically modified (2\'-OMe) at no extra charge for increased stability and enhanced knockdown in vitro and in vivo.
horiz bar
 SSL   Follow us on Facebook Follow us onTwitter Follow us on Google Plus Connect us on LinkedIn Subscribe to our RSS Feed for latest products and special promotions